Rafferty Asset Management, LLC Abbott Laboratories Transaction History

Rafferty Asset Management, LLC

  • $22.9 Billion
  • Q1 2025

A detailed history of Rafferty Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 160,596 shares of ABT stock, worth $20.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
160,596
Previous 196,706 18.36%
Holding current value
$20.6 Million
Previous $22.2 Million 4.25%
% of portfolio
0.09%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$111.1 - $140.22 $4.01 Million - $5.06 Million
-36,110 Reduced 18.36%
160,596 $21.3 Million
Q4 2024

Feb 14, 2025
BUY
$111.93 - $119.39 $2.27 Million - $2.42 Million
20,236 Added 11.47%
196,706 $22.2 Million
Q3 2024

Nov 13, 2024
SELL
$100.07 - $118.13 $1.27 Million - $1.5 Million
-12,730 Reduced 6.73%
176,470 $20.1 Million
Q2 2024

Aug 13, 2024
BUY
$100.73 - $112.44 $1.01 Million - $1.13 Million
10,042 Added 5.61%
189,200 $19.7 Million
Q1 2024

May 13, 2024
BUY
$109.52 - $120.96 $274,895 - $303,609
2,510 Added 1.42%
179,158 $20.4 Million
Q4 2023

Feb 13, 2024
SELL
$90.19 - $110.4 $398,820 - $488,188
-4,422 Reduced 2.44%
176,648 $19.4 Million
Q3 2023

Nov 13, 2023
BUY
$95.53 - $114.62 $1.22 Million - $1.47 Million
12,809 Added 7.61%
181,070 $17.5 Million
Q2 2023

Aug 11, 2023
BUY
$100.78 - $112.29 $1.24 Million - $1.38 Million
12,267 Added 7.86%
168,261 $18.3 Million
Q1 2023

May 11, 2023
BUY
$96.86 - $114.01 $579,029 - $681,551
5,978 Added 3.98%
155,994 $15.8 Million
Q4 2022

Feb 13, 2023
BUY
$95.06 - $111.52 $5.35 Million - $6.28 Million
56,324 Added 60.12%
150,016 $16.5 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $4.95 Million - $5.74 Million
51,209 Added 120.54%
93,692 $9.07 Million
Q2 2022

Aug 12, 2022
SELL
$102.07 - $123.37 $1.18 Million - $1.43 Million
-11,568 Reduced 21.4%
42,483 $4.62 Million
Q1 2022

May 13, 2022
SELL
$114.02 - $139.04 $613,883 - $748,591
-5,384 Reduced 9.06%
54,051 $6.4 Million
Q4 2021

Feb 10, 2022
BUY
$115.53 - $141.46 $336,307 - $411,790
2,911 Added 5.15%
59,435 $8.37 Million
Q3 2021

Nov 10, 2021
BUY
$116.66 - $129.06 $2.01 Million - $2.22 Million
17,206 Added 43.76%
56,524 $6.68 Million
Q2 2021

Aug 10, 2021
BUY
$105.79 - $124.53 $398,722 - $469,353
3,769 Added 10.6%
39,318 $4.56 Million
Q1 2021

May 10, 2021
BUY
$108.84 - $128.23 $344,369 - $405,719
3,164 Added 9.77%
35,549 $206 Million
Q4 2020

Feb 10, 2021
SELL
$105.0 - $114.42 $254,310 - $277,125
-2,422 Reduced 6.96%
32,385 $3.55 Million
Q3 2020

Nov 13, 2020
SELL
$91.64 - $111.29 $1.04 Million - $1.27 Million
-11,396 Reduced 24.67%
34,807 $3.79 Million
Q2 2020

Aug 07, 2020
BUY
$76.57 - $98.0 $2.27 Million - $2.91 Million
29,697 Added 179.92%
46,203 $4.22 Million
Q1 2020

May 15, 2020
SELL
$62.82 - $91.86 $1.96 Million - $2.87 Million
-31,221 Reduced 65.42%
16,506 $1.3 Million
Q4 2019

Feb 10, 2020
BUY
$78.51 - $87.4 $3.5 Million - $3.89 Million
44,527 Added 1391.47%
47,727 $4.15 Million
Q3 2019

Nov 14, 2019
SELL
$81.84 - $88.74 $500,287 - $542,467
-6,113 Reduced 65.64%
3,200 $268,000
Q2 2019

Aug 09, 2019
SELL
$72.88 - $85.0 $167,478 - $195,330
-2,298 Reduced 19.79%
9,313 $783,000
Q1 2019

May 15, 2019
BUY
$66.22 - $80.06 $768,880 - $929,576
11,611 New
11,611 $928,000
Q4 2018

Feb 11, 2019
SELL
$65.56 - $74.27 $197,991 - $224,295
-3,020 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$60.81 - $73.36 $183,646 - $221,547
3,020 New
3,020 $222,000
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $2.77 Million - $3.06 Million
-48,154 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$56.27 - $63.62 $2.71 Million - $3.06 Million
48,154 New
48,154 $2.89 Million

Others Institutions Holding ABT

# of Institutions
3,577
Shares Held
1.38B
Call Options Held
9.72M
Put Options Held
8.83M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email